Neurodegenerative Disease Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 17
SKU : PH2090
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
loading
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
Request new version
FAQ’s
What is the Projected CAGR value of the Neurodegenerative Disease Market?
Neurodegenerative Disease Market is expected to grow at a CAGR of 7.4% during the forecast period 2024-2031.
Who are the Key players contributing to the market's growth?
Major players are AbbVie Inc., Amneal Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Merck & Co. Inc., Pfizer Inc., Teva Pharmaceutical, UCB SA and Novartis.
Related Reports
pharmaceuticals

Huntington's Disease Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 18
Starting from

$4350

pharmaceuticals

Parkinson’s disease Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 11
Starting from

$4350

biotechnology

Regenerative Medicine Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 January 10
Starting from

$4350

pharmaceuticals

Neuromuscular Disease Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 March 04
Starting from

$4350

pharmaceuticals

Non-Proliferative Diabetic Retinopathy Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 05
Starting from

$4350

pharmaceuticals

Macular Degeneration Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 February 22
Starting from

$4350